Recent advances in the understanding of the pathogenesis of insulin-dependent diabetes mellitus (IDDM) have led to the first trials of disease prevention in susceptible individuals. Two main trials (nicotinamide and insulin) are now running but first results will not be available before the turn of
Insulin-dependent diabetes mellitus: ethical considerations for prevention trials
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 97 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0742-4221
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The prevalence of non-insulin-dependent (Type 2) diabetes mellitus (NIDDM) is increasing worldwide. Although recent studies suggest that primary prevention of NIDDM is possible, strategies for controlling the NIDDM pandemic remain under development. Successful interventions to date have mainly relie
Graft recurrence of insulin-dependent diabetes mellitus (IDDM) was examined. Islet transplantation or pancreasalone transplantation excluding the duodenum and peripancreatic lymph nodes was compared with whole pancreaticoduodenal transplantation. A Wistar Furth (WF; RT1 u , RT6.2) to major histocomp
Identification of risk factors for development of diabetic sensorimotor peripheral neuropathy (DSPN) and diabetic autonomic neuropathy (DNA) may help to prevent or modify these complications. The ABCD Trial, a prospective study of diabetic complications, has identified risk factors of the presence a
The use of traditional plant medicines, as well as the factors associated with their use, were documented in 662 outpatients with non-insulin dependent diabetes mellitus enrolled at six primary care clinics in South Texas. Forty-nine percent of the patients reported using alternative treatments for